Mode
Text Size
Log in / Sign up

Novel biomarkers and machine learning algorithms facilitate earlier identification and diagnosis of sepsisNew Diagnostic Tools May Help Identify Sepsis More Quickly

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that machine learning and novel biomarkers like sTREM-1 may improve early identification of sepsis cases.

This narrative review synthesizes current diagnostic strategies for sepsis, focusing on the transition from traditional clinical scoring systems to advanced biochemical markers and computational tools. The scope includes an evaluation of the SOFA score alongside newer inflammatory biomarkers such as sTREM-1 and presepsin.

The authors highlight a shift toward more sophisticated identification methods, including Sepsis ImmunoScore and various machine learning algorithms. These technologies are presented as advancements over routine clinical scoring for identifying patients requiring early intervention. The review emphasizes the evolution of diagnostic tools to improve precision in sepsis management.

A notable limitation is that the review summarizes these technological advances but does not provide specific trial data or statistical evidence regarding the efficacy of any single marker. Clinical utility is framed around providing a reference for identification rather than establishing definitive superiority of one method over another. Practice relevance centers on the potential for earlier clinical detection and more precise diagnosis in sepsis cases.

How this fits prior evidence

This review addresses gaps in early identification by highlighting advanced biomarkers like sTREM-1 and presepsin, which may offer more nuanced data than traditional scores. It complements existing evidence regarding HMGB1 levels as a marker for mortality risk and Cystin C's AUC of 0.88 for sepsis-associated acute kidney injury. While the review focuses on diagnostic tools, it builds upon known markers of severity and complications in sepsis patients.

Sepsis is a serious condition that requires fast identification. This review looks at how doctors find the illness early. It compares older methods, like the SOFA score, with newer tools such as sTREM-1 and presepsin. These new markers are being studied to see if they can provide a faster diagnosis than traditional clinical scores.

In addition to biological markers, the review explores high-tech solutions. These include the Sepsis ImmunoScore and machine learning algorithms. These tools aim to use complex data to spot signs of infection more accurately. Because this is a narrative review, it summarizes existing information rather than testing these tools in a new clinical trial.

It is important to note that while these technologies show promise for early detection, the review does not provide specific statistics on how well each individual tool works. These methods are currently being explored as ways to improve diagnosis and precision. Patients should talk with their doctors about current standards of care.

What this means for you:
New biomarkers and machine learning may help identify sepsis earlier than traditional scoring systems alone.

Common questions

What are the new ways to detect sepsis?

Doctors are moving toward using novel biomarkers like sTREM-1 and presepsin. They are also looking into advanced tools such as the Sepsis ImmunoScore and machine learning algorithms. These methods aim to provide more precise diagnosis than traditional clinical scoring systems like the SOFA score.

How do these new tests differ from current ones?

Traditional methods often rely on the SOFA score and routine inflammatory markers. The newer methods mentioned in this review include specific biomarkers (sTREM-1, presepsin) and intelligent techniques like machine learning to help identify infections earlier.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedJul 2026
View Original Abstract ↓
Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection. Characterized by acute onset, rapid progression and high mortality, it poses a major global public health challenge in critical care medicine. Early accurate screening and diagnosis are crucial to improving patient prognosis and reducing mortality. In recent years, with the rapid advancement of medical technology, early screening and diagnostic strategies for sepsis have been continuously updated. Diagnostic approaches have evolved from traditional clinical scoring systems such as the The Sequential Organ Failure Assessment (SOFA) score and routine inflammatory biomarker detection to novel biomarkers including soluble Triggering Receptor Expressed on Myeloid cells-1(sTREM-1) and soluble cluster of differentiation 14 subtype (presepsin), as well as intelligent diagnostic techniques represented by Sepsis ImmunoScore and machine learning algorithms. Based on recent domestic and international research evidence, this narrative review summarizes the latest advances in early screening and diagnosis of sepsis, analyzes the strengths and limitations of various modalities, and provides references for early clinical identification and precise diagnosis of sepsis.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.